Basic Medical Theory Research

[1] KHIZAR S, ALRUSHAID N, ALAM KHAN F, et al. Nanocarriers based novel and effective drug delivery system[J]. Int J Pharm, 2023,632:122570.
[2] ALMEIDA B, NAG OK, ROGERS KE, et al. Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery[J]. Molecules,2020,25(23):5672.
[3] GUIMARãES D, CAVACO-PAULO A and NOGUEIRA E. Design of liposomes as drug delivery system for therapeutic appli cations[J].Int J Pharm,2021,601:120571.
[4] DATTA D, PRIYANKA BANDI S, COLACO V, et al. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics[J].Int J Pharm,2024,658:124192.
[5] QU F, SUN Y, BI D, et al. Regulating Size and Charge of Liposomes in Microneedles to Enhance Intracellular Drug Deli very Efficiency in Skin for Psoriasis Therapy[J]. Adv Healthc Mater,2023,12(31):e2302314.
[6] CHAW SY, NOVERA W, CHACKO AM, et al. In vivo fate of liposomes after subconjunctival ocular delivery[J]. J Control Release,2021,329:162-174.
[7] SPLEIS H, SANDMEIER M, CLAUS V, et al. Surface design of nanocarriers: Key to more efficient oral drug delivery syst ems[J].Adv Colloid Interface Sci,2023,313:102848.
[8] SHIMOKAWA T,FUKUTA T, INAGI T, et al. Protective effect of high-affinity liposomes encapsulating astaxanthin against corneal disorder in the in vivo rat dry eye disease model[J]. J Clin Biochem Nutr,2020,66(3):224-232.
[9] LV Y,ZHAI C,SUN G,et al.Chitosan as a promising mater ials for the construction of nanocarriers for diabetic retinop athy:an updated review[J].J Biol Eng,2024,18(1):18.
[10] BADRAN MM, ALOMRANI AH, ALMOMEN A, et al. Novel Metoprolol-Loaded Chitosan-Coated Deformable Liposomes in Thermosensitive In Situ Gels for the Management of Glaucoma: A Repurposing Approach[J].Gels,2022,8(10): 635.
[11] DOS SANTOS GA, FERREIRA-NUNES R, DALMOLIN LF, et al. Besifloxacin liposomes with positively charged additives for an improved topical ocular delivery[J]. Sci Rep, 2020, 10(1):19285.
[12] ZHANG Y,ZHOU T,WANG K,et al. Corneal Mucin-Targeting Liposome Nanoplatforms Enable Effective Treatment of Dry Eye Diseases by Integrated Regulation of Ferroptosis and Inflammation[J].Adv Sci (Weinh), 2024):e2411172.
[13] CANATO E, GRIGOLETTO A, ZANOTTO I, et al. Anti-HER2 Super Stealth Immunoliposomes for Targeted-Chemotherapy [J].Adv Healthc Mater,2023,12(29):e2301650.
[14] SAADH MJ,MUSTAFA MA,KUMAR A,et al.Stealth Nanocarr iers in Cancer Therapy:a Comprehensive Review of Design, Func tionality, and Clinical Applications[J]. AAPS PharmSciTech, 2024,25(6):140.
[15] KIAIE SH, MAJIDI ZOLBANIN N, AHMADI A, et al. Recent advances in mRNA-LNP therapeutics:immunological and pharma cological aspects[J].J Nanobiotechnology,2022,20(1):276.
[16] MIRJALILI MOHANNA SZ, DJAKSIGULOVA D, HILL AM, et al. LNP-mediated delivery of CRISPR RNP for wide-spread in vivo genome editing in mouse cornea[J]. J Control Release, 2022, 350:401-413.
[17] WANG Y, LI H, RASOOL A, et al. Polymeric nanoparticles (PNPs)for oral delivery of insulin[J]. J Nanobiotechnology, 2024,22(1):1.
[18] ROCHA CV, GONçALVES V, DA SILVA MC, et al. PLGA-Based Composites for Various Biomedical Applications[J]. Int J Mol Sci,2022,23(4):2034.
[19] BAO H,TIAN Y,WANG H,et al. Exosome-loaded degradable polymeric microcapsules for the treatment of vitreoretinal diseases[J].Nat Biomed Eng,2024,8(11):1436-1452.
[20] ALOTAIBI H, HATAHET T and AL-JAMAL WT. Indocyanine green J-aggregate (IJA)theranostics:Challenges and opportu nities[J].Int J Pharm,2024,661:124456.
[21] LIU F, CHEN Y, LI Y, et al. Folate-receptor-targeted laser-activable poly(lactide-co-glycolic acid) nanoparticles loaded with paclitaxel/indocyanine green for photoacoustic/ ultrasound imaging and chemo/photothermal therapy[J]. Int J Nanomedicine,2018,13:5139-5158.
[22] JAFERNIK K,ŁADNIAK A,BLICHARSKA E,et al. ChitosanBased Nanoparticles as Effective Drug Delivery Systems-A review[J].Molecules,2023,28(4):1963.
[23] CHAIYASAN W, PRAPUTBUT S,KOMPELLA UB,et al. Penetrat ion of mucoadhesive chitosan-dextran sulfate nanoparticles into the porcine cornea[J].Colloids Surf B Biointerfaces, 2017,149:288-296.
[24] HASSAN H, ALI AI, ELDESAWY EM, et al. Pharmacokinetic and Pharmacodynamic Evaluation of Gemifloxacin Chitosan Nanoparticles As an Antibacterial Ocular Dosage Form[J]. J Pharm Sci,2022,111(5):1497-1508.
[25] ALBARQI HA, GARG A, AHMAD MZ, et al. Recent Progress in Chitosan-Based Nanomedicine for Its Ocular Application in Glaucoma[J].Pharmaceutics,2023,15(2): 681.
[26] PANDIT J,SULTANA Y and AQIL M.Chitosan coated nanopa rticles for efficient delivery of bevacizumab in the posterior ocular tissues via subconjunctival administration[J]. Carboh ydr Polym,2021,267:118217.
[27] ALKHOLIEF M, KALAM MA, ALSHEMEMRY AK, et al. Topical Application of Linezolid-Loaded Chitosan Nanoparticles for the Treatment of Eye Infections[J]. Nanomaterials (Basel), 2023,13(4):681.
[28] SUN Z,LI T,MEI T,et al. Nanoscale MOFs in nanomedicine applications: from drug delivery to therapeutic agents[J]. J Mater Chem B,2023,11(15):3273-3294.
[29] TANG Y, HAN Y, ZHAO J, et al. A Rational Design of Metal-Organic Framework Nanozyme with High-Performance Copper Active Centers for Alleviating Chemical Corneal Burns [J].Nanomicro Lett,2023,15(1):112.
[30] LI B,ASHRAFIZADEH M and JIAO T.Biomedical applicati on of metal-organic frameworks (MOFs) in cancer therapy: Stimuli-responsive and biomimetic nanocomposites in targe ted delivery, phototherapy and diagnosis[J]. Int J Biol Macro mol,2024,260(Pt 2):129391.
[31] LIU S, DONG J, FANG X, et al. Nanoscale Zinc-Based Metal-Organic Frameworks Induce Neurotoxicity by Disturbing the Metabolism of Catecholamine Neurotransmitters[J]. Envir on Sci Technol, 2023, 57(13): 5380-5390.
[32] PARSAEI M, AKHBARI K, TYLIANAKIS E, et al. Effects of Fluorinated Functionalization of Linker on Quercetin Encaps ulation, Release and Hela Cell Cytotoxicity of Cu-Based MOFs as Smart pH-Stimuli Nanocarriers[J]. Chemistry, 2024, 30(1):e202301630.
[33] CHOI W and KOHANE DS. Hybrid Nanoparticle-Hydrogel Systems for Drug Delivery Depots and Other Biomedical Applic ations[J].ACS Nano,2024,18(34):22780-22792.
[34] LIU YC, LIN YK, LIN YT, et al. Injectable, Antioxidative, and Tissue-Adhesive Nanocomposite Hydrogel as a Potential Treatment for Inner Retina Injuries[J]. Adv Sci (Weinh), 2024, 11(11):e2308635.
[35] LEE S, HONG HK, SONG JS, et al. Intravitreal injectable hydrogel rods with long-acting bevacizumab delivery to the retina[J].Acta Biomater,2023,171:273-288.
[36] XEROUDAKI M, RAFAT M,MOUSTARDAS P,et al.A doublecrosslinked nanocellulose-reinforced dexamethasone-loaded collagen hydrogel for corneal application and sustained anti-inflammatory activity[J].Acta Biomater,2023,172:234-248.
[37] ZHOU Y, ZHAO C, SHI Z, et al. A Glucose-Responsive Hydrogel Inhibits Primary and Secondary BRB Injury for Retinal Microenvironment Remodeling in Diabetic Retinopathy [J].Adv Sci (Weinh),2024,11(32):e2402368.
[38] CHEN Y and FENG X. Gold nanoparticles for skin drug delivery[J].Int J Pharm,2022,625:122122.
[39] HAASE A,MIROSCHNIKOV N,KLEIN S,et al.New retinoblast oma(RB) drug delivery approaches: anti-tumor effect of atrial natriuretic peptide (ANP)-conjugated hyaluronic-acid-coated gold nanoparticles for intraocular treatment of chemoresista nt RB[J].Mol Oncol,2024,18(4):832-849.
[40] ALHOWYAN AA, KALAM MA, IQBAL M, et al. Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies[J].Molecules,2023,28(3):1260.
[41] PAIVA MRB, ANDRADE GF, DOURADO LFN, et al. Surface functionalized mesoporous silica nanoparticles for intravitr eal application of tacrolimus[J]. J Biomater Appl, 2021, 35(8):1019-1033.
[42] WU M, WANG S, WANG Y, et al. Targeted delivery of mitomycin C-loaded and LDL-conjugated mesoporous silica nanoparticles for inhibiting the proliferation of pterygium subconjunctival fibroblasts[J].Exp Eye Res,2020,197:108124.
[43] AMATO R,GIANNACCINI M,DAL MONTE M, et al. Association of the Somatostatin Analog Octreotide With Magnetic Nanopar ticles for Intraocular Delivery: A Possible Approach for the Treatment of Diabetic Retinopathy[J]. Front Bioeng Biotech nol,2020,8:144.
[44] BASSETTO M, AJOY D, POULHES F, et al. Magnetically Assisted Drug Delivery of Topical Eye Drops Maintains Retinal Function In Vivo in Mice[J].Pharmaceutics,2021,13(10):1650.